dose administration, but interestingly comparing unbound drug concentrations following 3 intravenous infusion at steady-state would provide exactly the same information (7) . The 4 advantage of steady-state conditions is to require a single concentration determination in 5 plasma and tissue, which is much more simple and probably more accurate than 6 determining AUCs after single dose administration. The feasibility and optimization of 7 such an alternative approach is now being tested using levofloxacin (LVX) as a 8 representative antibiotic. buffer (pH=7) (1/1, vol/vol). Both compounds were analyzed at the same wavelengths: 22 λex=285 nm, λem=490 nm. The between-day variability of the assay was characterized 23 6 each day of the analysis and was respectively less than 20% and 10% at two 1 concentrations levels (0.125 and 1 µg.mL -1 ). 2 3 Steady-state conditions preclude the retrodialysis by drug method to estimate probes 4 recoveries, and considering that our objective was to conduct an experiment within a 5 limited period of time, the retrodialysis by calibrator method was the best method for 6 that. CIP had been previously validated as an appropriate calibrator for another 7 fluoroquinolone antibiotic, norfloxacin (NOR) (16). It was therefore tested again as a 8 potential calibrator for LVX. In vitro recoveries by gain and by loss of CIP and LVX 9
were not statistically different (data not shown). Differences between LVX and CIP in 10 vivo recoveries by loss in blood, muscle and lung, were always lower than 7%, with only 11 an exception for Rat C in lung (Table 1) . 12 13 Individual values of CIP recoveries by loss determined in rats receiving LVX (Rats 1-8) 14 are presented in Table 2 . These values were generally consistent with those obtained 15 during the validation phase (Rats A-C), although relatively higher recoveries were 16 occasionally observed especially in blood. Recovery by loss of CIP in lung was 3 to 4 17 folds lower on average than in muscle or blood (Table 2) , again consistent with 18 observations made in Rats A-C, as well as with previous experiments (6, 17). These 19 relatively low recoveries in lung are most likely due to the different nature and cut-off of 20 the membrane compared to CMA/20 probes. The between rats variability in lung probes 21 recoveries, with extreme values ranging between 9.2 ± 3.6% and 31.5 ± 7.5% was also 22 larger than in other media (Table 2) . Altogether these data suggest that CIP may be 23 and published mostly by researchers from the same group (1, 11, 22, 24) . The first LVX 22 microdialysis distribution study in human was conducted in the skeletal muscle tissue of 23 8 patients with sepsis (22) . Unbound plasma concentrations were derived from measured 1 total plasma concentrations assuming an average fraction bound equal to 35%. Ratio of 2 the tissue to plasma unbound AUCs from time 0 to 8h (AUC 0-8 ) was used to characterize 3 LVX distribution and was estimated to 0.85. The second study was conducted in 4 subcutaneous adipose tissue using similar procedure, except that AUCs were estimated 5 from time 0 to 10h and plasma protein binding was assumed to be equal to 25% (1). 6
Average tissue to plasma unbound AUCs ratios were again close to unity (1.1 ± 0.6 for 7 healthy and 1.2 ± 1.0 for inflamed subcutaneous adipose tissue). The third article 8 describes the first microdialysis distribution study in lung (11) and lead to the conclusion 9 that LVX penetration in this tissue was lower than in muscle (22) or subcutaneous 10 adipose tissue (1). However in this study unbound AUCs of LVX in lung were compared 11 to total plasma AUCs, with a mean ratio equal to 0.6. Therefore after correcting plasma 12 AUC for protein binding as previously done by these authors, and considering that 30% 13 of LVX is bound in plasma, one would obtain a mean tissue to plasma unbound AUCs 14 ratio equal to 1.9, that is actually higher than the previously reported values close to unity 15 (1, 22 ). The last study was then conducted to clarify the apparently conflicting data 16 between muscle or subcutaneous tissue and lung (24). Unfortunately distinct subjects 17 were enrolled in the study with muscle and subcutaneous distribution being investigated 18 in healthy volunteers and lung distribution in patients undergoing elective lung surgery. 19
Furthermore unbound tissue concentrations determined by microdialysis were again 20 compared with total plasma concentrations making AUCs ratios interpretation difficult, 21 especially since LVX plasma protein binding may vary between healthy volunteers and 22
patients. But interestingly in this last study total AUCs were used to characterize LVX 23 tissue distribution. Unfortunately microdialysate samples were collected over a 8 h period 1 of time, which considering the delayed peak in tissue (between 1h and 3h) and the 2 relatively long elimination half-life of LVX (estimated to 5-6h in this study), does not 3 allow precise estimation of total AUCs. This study lead to the conclusion that LVX levels 4 in the ECF of soft tissues cannot serve as a surrogate for predicting its pharmacokinetics 5 in lung (24), whereas the results of our study that was conducted in rats but measuring 6 LVX concentrations in both tissues of each animal, suggest the opposite. 7
8
Microdialysis tissue distribution studies following single doses administrations should 9 rely on the comparison between total unbound AUCs in tissue and plasma (7), but as 10 exemplified by this series of studies conducted with LVX this is not always done, and it 11 may be difficult to accurately estimate these total AUCs. On many occasions AUCs 12 between two consecutive administrations at steady-state should be equal to total AUCs 13 after single doses, but they may not be more practical to estimate. Therefore comparison 14 of tissue ECF and plasma unbound concentrations following intravenous infusion at 15 steady-state appears as an interesting alternative to characterize drug tissue distribution, 16 in particular to look for active efflux transport phenomenon. Although a single 17 concentration measurement in tissue and plasma would be enough from a theoretical 18 standpoint, six consecutive series of determinations were conducted for this initial study. 
